Study details
Enrolling now
Nitrous Oxide as Treatment for Fibromyalgia
University of Chicago
NCT IDNCT05357066ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
50
Study length
about 5.1 years
Ages
18–75
Locations
1 site in IL
What this study is about
Researchers are testing whether nitrous oxide can help reduce pain in people with fibromyalgia, a chronic condition causing widespread musculoskeletal pain. The trial will compare the effects of nitrous oxide to a placebo (an inactive substance).
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Nitrous oxide gas for inhalation
- 2.Take Placebo
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
inhaled
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
anesthetic (Inhaled anesthetic gas; causes analgesia and mild anesthesia)
Drug routes
inhaled
Endpoints
Secondary: Hospital Anxiety and Depression Scale
Body systems
Musculoskeletal